Related Experiment Video
Updated: Mar 20, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase
Michael Kaplan1, Cathy Hammerman1, Vinod K Bhutani2
1Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, P.O. Box 12271, Jerusalem, 9112102 Israel; Department of Neonatology, Shaare Zedek Medical Center, PO Box 3235, Jerusalem 91031, Israel.
Insights
Prematurity and glucose-6-phosphate dehydrogenase (G6PD) deficiency increase the risk of severe neonatal jaundice. Vigilant observation for jaundice in preterm infants with G6PD deficiency is crucial to prevent potential brain damage.
Area of Science:
- Neonatology
- Hematology
- Genetics
Background:
- Prematurity and glucose-6-phosphate dehydrogenase (G6PD) deficiency are significant risk factors for neonatal hyperbilirubinemia.
- These conditions can interact, leading to severe hyperbilirubinemia and potential bilirubin neurotoxicity.
- Neonatal jaundice in these infants results from acute hemolysis and immature bilirubin conjugation.
Purpose of the Study:
- To highlight the combined risks of prematurity and G6PD deficiency in neonatal hyperbilirubinemia.
- To emphasize the unpredictable nature of hemolysis in G6PD-deficient infants.
- To underscore the importance of monitoring preterm infants with G6PD deficiency for jaundice.
Main Methods:
- Literature review on prematurity, G6PD deficiency, and neonatal hyperbilirubinemia.
- Analysis of the pathophysiological mechanisms of hyperbilirubinemia in affected neonates.
- Clinical observation and risk assessment strategies.
Main Results:
- Combined prematurity and G6PD deficiency pose a substantial risk for extreme neonatal jaundice.
- Hemolysis episodes can be sudden and unpredictable, exacerbated by immature bilirubin conjugation.
- Preventing known triggers reduces but does not eliminate hemolysis risk.
Conclusions:
- Preterm infants with G6PD deficiency require close monitoring for jaundice, both in-hospital and post-discharge.
- Early detection and management are essential to prevent bilirubin neurotoxicity.
- Awareness of interacting risk factors is critical for neonatal care.
Abstract:
Prematurity and glucose-6-phosphate dehydrogenase (G6PD) deficiency are risk factors for neonatal hyperbilirubinemia. The 2 conditions may interact additively or synergistically, contributing to extreme hyperbilirubinemia, with the potential for bilirubin neurotoxicity. This hyperbilirubinemia is the result of sudden, unpredictable, and acute episodes of hemolysis in combination with immaturity of bilirubin elimination, primarily of conjugation. Avoidance of contact with known triggers of hemolysis in G6PD-deficient individuals will prevent some, but not all, episodes of hemolysis. All preterm infants with G6PD deficiency should be vigilantly observed for the development of jaundice both in hospital and after discharge home.
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Rh Blood Group
Other Glycolytic Pathways

